ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

50
Analysis
Health CareAustralia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
03 Jan 2022 00:01

Australian Healthcare: High Growth Ideas for 2022

Australian equity market is expected to continue its superior performance in 2022. This insight has highlighted five high growth healthcare ideas,...

Logo
312 Views
Share
bullishImugene Ltd
21 Sep 2021 09:37

ASX100/​200 Index Rebalance Preview: Potential December Changes With Large Impact

There could be 1 change to the ASX100 and 5 changes to the ASX200 at the December rebalance. With a long M&A pipeline, there could be additional...

Logo
539 Views
Share
13 Dec 2017 17:44

Aussie Healthcare Daily: 12 & 13 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
416 Views
Share
x